Jupiter Life Line Hospitals Schedules Board Meeting on May 15, 2026 to Review Q4FY26 Results and Consider Share Split

1 min read     Updated on 11 May 2026, 11:01 PM
scanx
Reviewed by
Suketu GScanX News Team
AI Summary

Jupiter Life Line Hospitals Limited has scheduled a board meeting on Friday, May 15, 2026, to consider audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board will also deliberate on declaring an interim dividend for FY 2025-26, with May 22, 2026 set as the record date. Additionally, a proposal for sub-division/split of equity shares with a face value of Rs. 10 each, fully paid up, is on the agenda, subject to shareholder and regulatory approvals. The Trading Window will remain closed for Designated Persons until 48 hours after the conclusion of the meeting.

powered bylight_fuzz_icon
40066301

*this image is generated using AI for illustrative purposes only.

Jupiter Life Line Hospitals Limited has informed the stock exchanges of a board meeting scheduled for Friday, May 15, 2026, pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting will take up several significant agenda items, including the review of audited financial results, a dividend declaration, and a share split proposal.

Key Agenda Items

The board meeting has been convened to consider a range of important corporate matters. The following table summarises the key agenda items scheduled for deliberation:

Agenda Item: Details
Financial Results: Audited Standalone and Consolidated results for Q4 and FY ended March 31, 2026
Interim Dividend: Consideration and declaration of interim dividend on equity shares for FY 2025-26
Share Split Proposal: Sub-division/split of equity shares with face value of Rs. 10 each, fully paid up
Record Date (Dividend): Friday, May 22, 2026

Interim Dividend and Record Date

In terms of Regulation 42 of the Listing Regulations, the company has set Friday, May 22, 2026 as the record date for determining shareholders entitled to receive the interim dividend for FY 2025-26, if declared by the Board of Directors. The dividend, if approved, will be paid on equity shares of the company.

Equity Share Split Proposal

The board will also consider a proposal for the sub-division/split of existing equity shares having a face value of Rs. 10 each, fully paid up. The manner of the split will be determined by the Board of Directors, subject to approval of the shareholders of the company and other requisite regulatory approvals.

Trading Window Closure

In accordance with the Company's Code of Conduct for Prevention, Regulation, Monitoring and Reporting of Insider Trading under the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading Window will remain closed for all Designated Persons and their Immediate Relatives until 48 hours from the conclusion of the board meeting.

The intimation has been filed with the National Stock Exchange of India Ltd. and BSE Limited, and will also be made available on the company's website at www.jupiterhospital.com , pursuant to Regulation 46(2) of the Listing Regulations. The notice was signed by Suma Upparatti, Company Secretary & Compliance Officer, on May 11, 2026.

What split ratio is Jupiter Life Line Hospitals likely to adopt for its equity shares, and how might this impact retail investor participation and stock liquidity?

How does Jupiter Life Line Hospitals' anticipated dividend payout compare to its historical dividend track record, and what does it signal about the company's cash flow health?

Could the share split proposal trigger increased institutional or retail investor interest, and what potential price movement patterns have similar hospital sector stocks exhibited post-split?

Jupiter Life Line Hospitals Limited Submits SEBI Compliance Certificate for Q4FY26

1 min read     Updated on 03 Apr 2026, 06:21 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Jupiter Life Line Hospitals Limited submitted its SEBI Regulation 74(5) compliance certificate for Q4FY26 ended March 31, 2026. KFin Technologies Limited, the company's Registrar and Share Transfer Agent, certified that the entire shareholding remains in dematerialized form with no rematerialization requests received during the quarter. The filing was submitted to NSE and BSE on April 3, 2026, by Company Secretary Suma Upparatti, demonstrating continued regulatory compliance.

powered bylight_fuzz_icon
36766280

*this image is generated using AI for illustrative purposes only.

Jupiter Life Line Hospitals Limited has filed its quarterly compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The healthcare company submitted the mandatory documentation to both the National Stock Exchange of India and BSE Limited on April 3, 2026.

Regulatory Compliance Filing

The certificate was submitted in compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Suma Upparatti signed the submission letter, forwarding the certificate received from the company's Registrar and Share Transfer Agent.

Filing Details: Information
Quarter Ended: March 31, 2026
Filing Date: April 3, 2026
NSE Symbol: JLHL
BSE Code: 543980
Compliance Officer: Suma Upparatti

Share Transfer Agent Certification

KFin Technologies Limited, serving as the Registrar and Share Transfer Agent, issued the compliance certificate on April 3, 2026. Vice President Dnyanesh Gharote signed the certification document, confirming that all required details regarding securities dematerialization and rematerialization have been furnished to the stock exchanges.

Dematerialization Status

The certificate confirms a significant operational milestone for the company's securities management:

  • The entire holding of Jupiter Life Line Hospitals Limited remains in demat form for the quarter ended March 31, 2026
  • No rematerialization requests were received during the reporting period
  • Complete digitization of shareholding maintained throughout the quarter

Stakeholder Communication

The compliance certificate was distributed to key market infrastructure institutions. KFin Technologies Limited copied the National Securities Depository Limited and Central Depository Services (India) Limited on the certification, ensuring comprehensive regulatory communication across the depository ecosystem.

The filing demonstrates the company's adherence to SEBI's regulatory framework for depositories and participants, maintaining transparency in its securities handling processes. The complete dematerialization status reflects the company's alignment with digital securities management practices in the Indian capital markets.

How might Jupiter Life Line Hospitals' complete dematerialization status impact its future fundraising capabilities and institutional investor interest?

What strategic expansion plans could the company be preparing for given its strong regulatory compliance framework?

Will SEBI introduce additional digital securities management requirements that could affect Jupiter Life Line's operational costs?

More News on Jupiter Life Line Hospital